Acasti Pharma reported $-2.88M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Acasti Pharma USD -2.88M 564K Mar/2026
Addus HomeCare USD 37.78M 5.35M Jun/2026
Amarin USD -852K 7.26M Dec/2025
Cassava Sciences USD -10.81M 33.41M Sep/2025
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Option Care Health USD 61M 20.51M Mar/2026
Organigram Holdings CAD -921K 40.8M Mar/2026
Tilray USD -39.96M 39.19M Sep/2025